193 related articles for article (PubMed ID: 32302510)
1. Targeted Alpha Therapy and Nanocarrier Approach.
Silindir-Gunay M; Karpuz M; Ozer AY
Cancer Biother Radiopharm; 2020 Aug; 35(6):446-458. PubMed ID: 32302510
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Particle Therapy for Multifocal Osteosarcoma: A Hypothesis.
Baranowska-Kortylewicz J; Sharp JG; McGuire TR; Joshi S; Coulter DW
Cancer Biother Radiopharm; 2020 Aug; 35(6):418-424. PubMed ID: 32073902
[TBL] [Abstract][Full Text] [Related]
3. Targeted Alpha Therapy: Current Clinical Applications.
Guerra Liberal FDC; O'Sullivan JM; McMahon SJ; Prise KM
Cancer Biother Radiopharm; 2020 Aug; 35(6):404-417. PubMed ID: 32552031
[TBL] [Abstract][Full Text] [Related]
4. Targeted Radioimmunotherapy and Theranostics with Alpha Emitters.
Pandit-Taskar N
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S41-S44. PubMed ID: 31451417
[TBL] [Abstract][Full Text] [Related]
5. The in vivo fate of
Kruijff RM; Raavé R; Kip A; Molkenboer-Kuenen J; Morgenstern A; Bruchertseifer F; Heskamp S; Denkova AG
Sci Rep; 2019 Aug; 9(1):11671. PubMed ID: 31406320
[TBL] [Abstract][Full Text] [Related]
6. Clinical Applications of Nanosized Drug-Delivery Systems in Lung Cancer Imaging and Therapy.
Karpuz M; Silindir-Gunay M; Ozer AY
Crit Rev Ther Drug Carrier Syst; 2020; 37(5):435-471. PubMed ID: 33389847
[TBL] [Abstract][Full Text] [Related]
7. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
8. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
[TBL] [Abstract][Full Text] [Related]
9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
10. Targeted α-Therapy.
Brechbiel MW
Cancer Biother Radiopharm; 2020 Aug; 35(6):397. PubMed ID: 32503377
[No Abstract] [Full Text] [Related]
11. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
12. Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.
; Parker C; Lewington V; Shore N; Kratochwil C; Levy M; Lindén O; Noordzij W; Park J; Saad F
JAMA Oncol; 2018 Dec; 4(12):1765-1772. PubMed ID: 30326033
[TBL] [Abstract][Full Text] [Related]
13. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
14. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
15. Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
Varghese OP; Liu J; Sundaram K; Hilborn J; Oommen OP
Biomater Sci; 2016 Aug; 4(9):1310-3. PubMed ID: 27431007
[TBL] [Abstract][Full Text] [Related]
16. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP
AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
[TBL] [Abstract][Full Text] [Related]
17. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceutical enhancement by drug delivery systems: A review.
Kleynhans J; Grobler AF; Ebenhan T; Sathekge MM; Zeevaart JR
J Control Release; 2018 Oct; 287():177-193. PubMed ID: 30086338
[TBL] [Abstract][Full Text] [Related]
19. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
